Use of the interleukin 6 inhibitor tocilizumab in Japanese patients with cytokine release syndrome caused by COVID-19-related acute respiratory distress syndrome: A case series

Detalles Bibliográficos
Autores principales: Nakamura, Hideta, Miyagi, Kazuya, Otsuki, Mariko, Higure, Yuuri, Nishiyama, Naoya, Kinjo, Takeshi, Nakamatsu, Masashi, Haranaga, Shusaku, Tateyama, Masao, Fujita, Jiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Respiratory Society. Published by Elsevier B.V. 2020
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7539801/
https://www.ncbi.nlm.nih.gov/pubmed/33067149
http://dx.doi.org/10.1016/j.resinv.2020.09.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7539801/
https://www.ncbi.nlm.nih.gov/pubmed/33067149
http://dx.doi.org/10.1016/j.resinv.2020.09.006

Ejemplares similares